Cite the Following Article
Microneedle-based ocular drug delivery systems – recent advances and challenges
Piotr Gadziński, Anna Froelich, Monika Wojtyłko, Antoni Białek, Julia Krysztofiak and Tomasz Osmałek
Beilstein J. Nanotechnol. 2022, 13, 1167–1184.
https://doi.org/10.3762/bjnano.13.98
How to Cite
Gadziński, P.; Froelich, A.; Wojtyłko, M.; Białek, A.; Krysztofiak, J.; Osmałek, T. Beilstein J. Nanotechnol. 2022, 13, 1167–1184. doi:10.3762/bjnano.13.98
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
| Picture with graphical abstract, title and authors for social media postings and presentations. | ||
| Format: PNG | Size: 9.1 MB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- He, A.; Chen, V.; Yu, J. Sustained ocular drug delivery via polydopamine chitosan curcumin nanocomposite coatings. Discover Nano 2026, 21. doi:10.1186/s11671-026-04556-z
- Zhao, Y.; Sun, Y.; Peng, J.; Gong, J.; Ren, X.; Gao, X.; Yang, S.; Li, L.; Ma, Y.; Wang, Y.; Liu, D. A co-amorphous salt of ursodeoxycholic acid and matrine incorporated into dissolving microneedles for combined antibacterial and anti-inflammatory treatment of acne vulgaris. International Journal of Pharmaceutics 2026, 697, 126887. doi:10.1016/j.ijpharm.2026.126887
- Guha, S.; Tharmatt, A.; Yadav, S.; Siwakoti, P.; Kumeria, T.; Mittal, A.; Chitkara, D. Lipid-polymer hybrid nanoplex loaded microneedle patches as a corneal delivery platform for CRISPR/Cas expressing plasmid. International journal of biological macromolecules 2026, 152092. doi:10.1016/j.ijbiomac.2026.152092
- Naik, S.; Arawindh, R.; Bharatam, S. T.; Bhala, S.; Venuganti, V. V. K. Dual drug loaded dissolvable annular microneedle patch to treat bacterial conjunctivitis. International journal of pharmaceutics 2026, 697, 126869. doi:10.1016/j.ijpharm.2026.126869
- Kong, J.; Shi, M.; Zhou, F.; Shi, L.; Cui, L.; Wu, C.; Tai, Z. Microneedle: classification, preparation and applications. International journal of pharmaceutics 2026, 696, 126826. doi:10.1016/j.ijpharm.2026.126826
- Jung, R.; Kao, E.; Guaiquil, V. H.; Djalilian, A. R.; Rosenblatt, M. I. Current and Developing Therapeutics for Dry Eye Disease: Targeting Ion Channels. Current issues in molecular biology 2026, 48, 332. doi:10.3390/cimb48030332
- Rusciano, D.; Gagliano, C.; Avitabile, A.; Maya-Vetencourt, J. F. Prostaglandin E1 in ischemic retinal diseases: mechanisms, evidence, and clinical perspectives. Frontiers in medicine 2026, 13, 1749690. doi:10.3389/fmed.2026.1749690
- D, N.; C, L. A.; B N, K. M.; Naveen, N. R. Reaching the Unreachable: Recent Advances and Challenges in Microneedles for Minimally Invasive Ocular Drug Delivery. Current Ophthalmology Reports 2026, 14. doi:10.1007/s40135-025-00345-6
- Jo, Y.; Gouya, C.; Mieler, W. F.; Kang-Mieler, J. J. Advancements and challenges in ophthalmic microneedles to treat eye diseases. Drug delivery 2026, 33, 2617688. doi:10.1080/10717544.2026.2617688
- Zong, Y.; Liu, J.; Yang, M.; Zhang, J.; Zou, Y.; Ye, Z.; Deng, J.; Gu, W.; Du, J.; Ohno-Matsui, K.; Kamoi, K. Advances in microneedle Technology for Treatment of retinal degenerative diseases: a narrative review. Biomedical microdevices 2026, 28, 5. doi:10.1007/s10544-025-00786-7
- Allahbedashti, T.; Sohail, M. The material–mucosa interface: A review of nanoformulations and biomaterials for overcoming transmucosal delivery barriers. Journal of Drug Delivery Science and Technology 2026, 115, 107655. doi:10.1016/j.jddst.2025.107655
- Samanta, S.; Srivastava, N. Ocular Delivery: Innovations in Ocular Inserts, Contact Lenses, and Microneedles. BIO Integration 2026, 7. doi:10.15212/bioi-2025-0128
- Datta, D.; Bandi, S. P.; Prabha H, A.; Halagali, P.; Tippavajhala, V. K.; Rathee, A. S. Emerging trends in ophthalmic products: Microneedles, hydrogels, and ocular inserts. Ophthalmic Drug Delivery; Elsevier, 2026; pp 111–170. doi:10.1016/b978-0-443-33781-9.00013-7
- Sabbagh, F.; Zargarian, S. S.; Kosik-Kozioł, A.; Nakielski, P.; Pierini, F. Hydrogel-based ocular drug delivery systems. Journal of materials chemistry. B 2025, 13, 14982–15006. doi:10.1039/d5tb01575h
- Feng, K.; Wei, M.; Ma, P.; Hu, J.; Huang, C.; Han, Y.; Liu, Z. Advances and challenges of targeted protein degradation in ophthalmology: Future directions and therapeutic potential. Materials & Design 2025, 259, 114767. doi:10.1016/j.matdes.2025.114767
- Baghban, R.; Khalili, M. R.; Zareei, A.; Talebnejad, M. R. Advancing glaucoma treatment with nanotechnology: a new frontier in ophthalmology. International journal of pharmaceutics 2025, 685, 126210. doi:10.1016/j.ijpharm.2025.126210
- Lee, J.; Jeong, J.; Nguyen, V. P.; Hong, S.; Paulus, Y. M.; Lee, C. H. Microneedles for controlled and sustained intraocular drug delivery. NPG Asia materials 2025, 17, 33. doi:10.1038/s41427-025-00614-7
- Roberts, P. A.; Thomas, C. N.; Bellamy Plaice, G.; Roberts, J. A.; Jones, M.-C.; Andrews, J. W.; Hill, L. J. Mathematical Models of Topically and Intravitreally Applied Ranibizumab. Investigative ophthalmology & visual science 2025, 66, 45. doi:10.1167/iovs.66.11.45
- Adak, S.; Jadhav, V. S.; Khatri, D. K. Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective. Drug delivery and translational research 2025, 16, 1064–1095. doi:10.1007/s13346-025-01925-6
- Elsherbiny, S. A.; El-Kamel, A. H.; Bakr, B. A.; Heikal, L. A. Microneedle loaded with luteolin-colostrum-derived exosomes: a dropless approach for treatment of glaucoma. Drug delivery and translational research 2025, 16, 613–634. doi:10.1007/s13346-025-01914-9
Patents
- FERNANDES JOSÉ. OPHTHALMIC COMPOSITIONS. WO 2024246753 A1, Dec 5, 2024.